Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study by Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee F R, Spencer T, Atomoxetine ADHD Study Group in Pediatrics (2001).

[PMID: 11694667] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.